TG Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	6,074	4,630	4,691	2,586	1,732	2,722
Market Cap Growth	-2.07%	-1.30%	81.36%	49.35%	-36.37%	-62.78%
Enterprise Value	6,313	4,740	4,632	2,478	1,652	2,484
Last Close Price	42.86	29.81	30.10	17.08	11.83	19.00
PE Ratio	14.93	10.76	200.67	189.78	-7.17	-7.22
Forward PE	25.56	20.29	45.21	-	-	-
PS Ratio	8.67	7.51	14.26	11.07	621.81	406.90
PB Ratio	10.42	7.14	21.09	16.11	29.56	11.48
P/TBV Ratio	11.82	7.43	21.70	15.80	27.34	10.59
P/FCF Ratio	-	-185.29	-115.64	-82.33	-9.83	-9.19
P/OCF Ratio	-	-186.89	-115.77	-82.33	-9.83	-9.21
EV/Sales Ratio	9.01	7.69	14.08	10.61	593.01	371.30
EV/EBITDA Ratio	42.21	38.42	110.30	118.89	-7.58	-7.21
EV/EBIT Ratio	42.23	38.44	110.48	120.11	-7.56	-7.20
EV/FCF Ratio	-	-189.72	-114.20	-78.89	-9.37	-8.39
Debt / Equity Ratio	1.29	0.39	1.14	0.68	1.39	0.32
Debt / EBITDA Ratio	5.04	2.06	6.04	5.32	-0.38	-0.23
Debt / FCF Ratio	-53.10	-10.15	-6.25	-3.53	-0.47	-0.27
Net Debt / Equity Ratio	0.41	0.17	-0.26	-0.66	-1.34	-0.99
Net Debt / EBITDA Ratio	1.60	0.91	-1.36	-5.12	0.36	0.68
Net Debt / FCF Ratio	-16.85	-4.47	1.41	3.40	0.45	0.80
Asset Turnover	0.54	0.75	0.73	0.89	0.01	0.01
Inventory Turnover	0.93	0.85	0.51	0.71	-	-
Quick Ratio	4.84	2.91	4.85	5.00	3.04	4.84
Current Ratio	5.81	4.10	6.25	5.92	3.16	5.06
Return on Equity (ROE)	75.03%	102.75%	12.21%	11.57%	-151.36%	-92.03%
Return on Assets (ROA)	-20.50%	-32.53%	10.04%	8.12%	-76.17%	-68.59%
Return on Invested Capital (ROIC)	-32.42%	-54.18%	35.78%	99.11%	2881.87%	3156.08%
Return on Capital Employed (ROCE)	13.28%	17.66%	10.99%	9.91%	-96.04%	-80.90%
Earnings Yield	7.60%	9.29%	0.50%	0.53%	-13.95%	-13.84%
FCF Yield	-0.23%	-0.54%	-0.86%	-1.21%	-10.17%	-10.88%
Buyback Yield / Dilution	2.27%	-0.67%	-7.96%	-9.67%	-2.41%	-14.64%
Total Shareholder Return	2.27%	-0.67%	-7.96%	-9.67%	-2.41%	-14.64%

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q